K Vickery

Author PubWeight™ 11.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Detection of persistent vegetative bacteria and amplified viral nucleic acid from in-use testing of gastrointestinal endoscopes. J Hosp Infect 1998 1.28
2 Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours. Vet Comp Oncol 2011 1.15
3 Is biofilm accumulation on endoscope tubing a contributor to the failure of cleaning and decontamination? J Hosp Infect 2004 1.15
4 Seroprevalence of markers for hepatitis B, C and G in male and female prisoners--NSW, 1996. Aust N Z J Public Health 1999 0.95
5 Duck hepatitis B virus: a model to assess efficacy of disinfectants against hepadnavirus infectivity. Epidemiol Infect 1991 0.91
6 The current pattern of hepatitis B virus infection in Australia. J Viral Hepat 2006 0.88
7 Biofilm removal by medical device cleaners: comparison of two bioreactor detection assays. J Hosp Infect 2010 0.84
8 Evaluation of image quality using 1 : 1 pitch and 1.5 : 1 pitch helical CT in children: a comparative study. Pediatr Radiol 1996 0.82
9 2',3'-dideoxy-3'-fluoroguanosine inhibits duck hepatitis B virus in vivo. J Viral Hepat 1996 0.81
10 Evaluation of disinfection and sterilization of reusable angioscopes with the duck hepatitis B model. J Vasc Surg 1999 0.79
11 The role of biofilm formation in percutaneous Kirschner-wire fixation of radial fractures. J Hand Surg Br 2002 0.76
12 Establishment of an in-use testing method for evaluating disinfection of surgical instruments using the duck hepatitis B model. J Hosp Infect 1996 0.76
13 Delipidation of a hepadnavirus: Viral inactivation and vaccine development. J Virol Methods 2006 0.76
14 Abuse of the National Health Service. Br Med J 1979 0.75
15 Vencor files for bankruptcy, employees will be paid. Provider 1999 0.75
16 The truth about cats and dogs. Weighing the pros and cons of pet therapy. Provider 1998 0.75
17 JCAHO issues assisted living accreditation principles. Provider 1999 0.75
18 Court gives a qualified nod to community placements. Provider 1999 0.75
19 Jostling for elbow room. As competition intensifies, assisted living companies broaden their services and look for new markets. Provider 1999 0.75
20 Long-term care on auction block. The key question is, who will own the companies? Provider 2000 0.75
21 Bankrupt chains regrouping as climate improves. Provider 2001 0.75
22 The hectic life of an MDS (minimum data set) coordinator. Provider 2001 0.75
23 The preparation, characterisation, and DNA adduct profile of 2-amino-2-methyl-3-butanoneoximedichloroplatinum(II), a platinum(II) complex designed to bind to GpA sequences of DNA. J Inorg Biochem 2000 0.75
24 Sun gains more time. Provider 2001 0.75
25 New Mexico to set new staffing levels for nursing facilities. Provider 2000 0.75
26 HCFA plans a quality check in financially troubled facilities. Provider 1999 0.75
27 Coxsackie group A in oysters and mussels. Lancet 1973 0.75
28 Fitting into a new role. Retrofitting a nursing facility to an assisted living residence is no easy task. Provider 1998 0.75
29 East and west of Eden. Caregivers choose from single-pet visits to Edenization. Provider 1998 0.75
30 Rebuilding through bankruptcy. Provider 2000 0.75
31 Mezzanine financing bridges mortgage gap. Provider 1998 0.75
32 Life at College Park. The challenges and triumphs of the people who live and work in ICFs/MR. Provider 1999 0.75
33 Quest for smaller, homelike settings spurs suits. ADA used in court cases seeking alternatives to ICFs/MR. Provider 1999 0.75
34 Identification of T-cell epitopes associated with immunity within the surface protein of duck hepatitis B virus. J Viral Hepat 2006 0.75
35 Synthetic leases offer genuine benefits. Provider 1998 0.75
36 Bill would expedite residents' return from hospital. Provider 1999 0.75
37 Community physician: a statutory consultant. Br Med J 1973 0.75
38 Top nursing facility chains. Provider 2000 0.75
39 Genesis Health Ventures restructures multicare acquisition. Provider 2000 0.75
40 Baltimore facilities battle over 'whites only' bequest. Provider 2000 0.75
41 Seniors housing still booming, not overbuilt, study says. Provider 1999 0.75
42 Corruption in Oklahoma. FBI probe uncovers criminal activity in nursing facility inspection process. Provider 2000 0.75
43 Postexposure treatment of experimental DHBV infection: a new therapeutic strategy. J Med Virol 1990 0.75
44 Bankruptcy update: a new name for Vencor, continued progress. Provider 2001 0.75
45 A market of contrasts. While stocks dry up, new financing options emerge for assisted living companies. Provider 1998 0.75
46 Surviving PPS. Provider 2000 0.75
47 Seniors housing especially popular with low-income seniors. Provider 1999 0.75
48 Going with the flow. Providers expand service to create a smooth continuum of care. Provider 2000 0.75
49 Assisted living's delicate balance. Operators face new challenges as they offer more nursing care. Provider 1997 0.75
50 The Y2K fix. Planning for business as usual despite potential disruptions, ranging from water to phone to finances. Provider 1999 0.75
51 California governor vetoes nursing facility reform bill. Provider 1999 0.75
52 IHS' reorganization plan taking shape. Provider 2001 0.75
53 Assisted living goes high tech. Provider 1998 0.75
54 Solomont Bailis walks where competitors haven't thought to tread--with an eye to the future. Provider 1999 0.75
55 Top 30 assisted living chains. Mergers, expansion drive shift in assisted living rankings. Provider 1999 0.75
56 Sun works to build reorganization deal. Provider 1999 0.75
57 Effects of Phyllanthus plant extracts on duck hepatitis B virus in vitro and in vivo. Antiviral Res 1992 0.75
58 Letter: Community medicine--a disclaimer. Br Med J 1974 0.75
59 Expansion strong in 1999 but will be slower next year. Provider 1999 0.75